Identification | More | [Name]
VITAMIN D3 | [CAS]
511-28-4 | [Synonyms]
5,7,10(19)-CHOLESTATRIEN-3BETA-OL-9,10-SECO 7-DEHYDROCHOLESTEROL 7-DEHYDROCHOLESTEROL ACTIVATED 9,10-SECOCHOLESTA-5,7,10(19)-TRIEN-3BETA-OL 9,10-SECOCHOLESTA-5,7,19(19)-TRIEN-3-OL-(3B,5Z,7E)-CHOLECIFEROL ACTIVATED 7-DEHYDROCHOLESTEROL ANTI-RACHITIC VITAMIN CALCIOL CHOLECALCIFEROL CHOLECALCIFEROLUM COLECALCIFEROL OLEOVITAMIN D3 RACUMIN D VITAMIN D (+)-VITAMIN D3 VITAMIN D3 9,10-secoergosta-5(Z),7(E),10(19)-trien-3beta-ol Duphafral VITAMINE D4 CHOLECALCIFEROL (VITAMIN D3) USP(CRM STANDARD) | [EINECS(EC#)]
200-673-2 | [Molecular Formula]
C27H44O | [MDL Number]
MFCD00078131 | [Molecular Weight]
384.64 | [MOL File]
511-28-4.mol |
Chemical Properties | Back Directory | [Melting point ]
83-86 °C(lit.) | [alpha ]
D18 +89.3° (c = 0.47 in acetone) | [Boiling point ]
504.9±29.0 °C(Predicted) | [density ]
0.96 | [storage temp. ]
2-8°C
| [solubility ]
Soluble in Chloroform | [form ]
Powder | [pka]
14.74±0.20(Predicted) | [color ]
Off-white to light yellow | [Stability:]
Hygroscopic, Temperature Sensitive | [CAS DataBase Reference]
511-28-4(CAS DataBase Reference) |
Safety Data | Back Directory | [Hazard Codes ]
T+ | [Risk Statements ]
R24/25:Toxic in contact with skin and if swallowed . R26:Very Toxic by inhalation. R48/25:Toxic: danger of serious damage to health by prolonged exposure if swallowed . | [Safety Statements ]
S28:After contact with skin, wash immediately with plenty of ... (to be specified by the manufacturer) . S36/37:Wear suitable protective clothing and gloves . | [RIDADR ]
UN 2811 6.1/PG 2
| [WGK Germany ]
2
| [RTECS ]
VS2900000
| [F ]
8-10-23 |
Hazard Information | Back Directory | [Description]
Derived from cholesterol, vitamin D is biosynthesized from its prohormone cholecalciferol (D3), the product of
solar ultraviolet irradiation of 7-dehydrocholesterol in the skin.
In 1966, it was first recognized that vitamin
D must undergo activation via two oxidative metabolic steps. The first oxidation to
25-hydroxycholecalciferol (25(OH)D3: calcifediol; Calderol) occurs in the endoplasmic reticulum of the liver and
is catalyzed by vitamin D 25-hydroxylase. This activation step is not
regulated by plasma calcium concentrations. The major circulating form (10–80 μg/mL) is 25(OH)D3, which also
is the primary storage form of vitamin D. | [Chemical Properties]
Pale Yellow Oil | [Uses]
Vitamin D4 is the active analogue of Vitamin D. | [Definition]
ChEBI: Vitamin D4 is it is present in mushrooms. It has a role as a fungal metabolite. It is a vitamin D and a seco-ergostane. | [Biological Functions]
Sterol-specific cytoplasmic receptor proteins (vitamin D receptor) mediate the biological action of vitamin D.
The active hormone is transported from the cytoplasm to the nucleus via the vitamin D receptor, and as a result
of the interaction of the hormone with target genes, a variety of proteins are produced that stimulate the
transport of calcium in each of the target tissues
Active vitamin D works in concert with PTH to enhance active
intestinal absorption of calcium, to stimulate bone resorption, and to prohibit renal excretion of calcium. If
serum calcium or 1,25-calcitriol concentrations are elevated, then vitamin D 24-hydroxylase (in renal
mitochondria) is activated to oxidize 25(OH)D3 to inactive 24,25-dihydroxy-cholecalciferol and to further oxidize
active vitamin D to the inactive 1,24,25-trihydroxylated derivative. Both the 1,24,25-trihydroxylated and the
24,25-dihydroxylated products have been found to suppress PT H secretion as well. The biosynthesis of vitamin D is tightly regulated based on the serum concentrations of calcium, phosphate, PTH, and active vitamin D.
| [storage]
Store at -20°C |
|
|